Smith+Nephew is a global medical technology company specializing in the repair, regeneration, and replacement of tissue and bone. With operations in more than 100 countries, the company focuses on delivering advanced solutions in orthopaedics, sports medicine, ENT (ear, nose, and throat), and wound care management. Smith+Nephew's innovative product portfolio supports faster healing, improved outcomes, and enhanced mobility for patients. By investing in minimally invasive technologies and smart surgical systems, it empowers medical professionals to improve patient recovery and quality of life.
The partnership with RMR Ortho adds a dynamic nitinol fixation solution to Smith & Nephew’s portfolio, enhancing surgical options for fracture and fusion procedures.
Smith+Nephew has signed a distribution agreement for the iFuse TORQ portfolio, enhancing its surgical solutions for percutaneous pelvic fracture fixation and sacroiliac joint fusion.
The new Category I CPT code, effective January 2027, recognises the CARTIHEAL implant’s proven efficacy, 87% risk reduction, and growing clinical adoption.
New CORIOGRAPH Pre-Op Planning for total shoulder arthroplasty enables 3D CT-based modeling, personalized biomechanics simulation, and integration with AETOS Shoulder System.
The CENTRIO PRP System supports natural healing for chronic wounds, including diabetic foot, venous leg, pressure, and tunneling ulcers, by maintaining a moist, biodynamic wound environment.
The TRIGEN MAX Tibia Nailing System aims to streamline operative procedures and provide efficiency through surgeon-centered design of components and instrumentation.
Smith+Nephew will showcase advanced robotics for personalized knee and hip surgery, the CATALYSTEM Hip System, OXINIUM implants for knee revisions, and the AETOS Stemless Shoulder System at AAOS 2025.